Stay updated on Subcutaneous Nivolumab + rHuPH20 Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.

Latest updates to the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange Detected- Revision: v3.4.2 updated; previous v3.4.1 removed; this is a minor administrative update that does not affect study content or user-facing details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision identifier updated from v3.4.0 to v3.4.1. This is a minor metadata update and does not affect study information or functionality.SummaryDifference0.0%

- Check27 days agoChange DetectedUI text updates include a new 'Show glossary' option, a 'Last Update Submitted that Met QC Criteria' label, a 'No FEAR Act Data' note, and a 'Revision: v3.4.0' tag. The prior labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.1%

- Check34 days agoChange DetectedThe Study Record Dates section now displays the label 'Last Update Posted' instead of 'Last Update Posted (Estimated)'. This is a minor labeling change to a timestamp field and does not alter study content or functionality.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page shows a minor revision update: addition of 'Revision: v3.3.4' and removal of 'Revision: v3.3.3'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedThe Locations section was updated with numerous additions and deletions across sites in the United States, Argentina, Brazil, Chile, France, Italy, Mexico, the Netherlands, New Zealand, Poland, Spain, the United Kingdom, and more (e.g., Georgia, Maryland, Michigan, North Carolina, Oregon, Rio Grande do Sul, Mexico City, North Holland, Bay of Plenty, Masovian Voivodeship, Glamorgan). Revision: v3.3.3 was posted, replacing the previous v3.3.2.SummaryDifference1%

Stay in the know with updates to Subcutaneous Nivolumab + rHuPH20 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.